• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“一切都取决于”:在卫生技术评估机构背景下对公众参与的概念化。

"It all depends": conceptualizing public involvement in the context of health technology assessment agencies.

机构信息

Institut National de Sante Publique du Quebec, National Collaborating Centre for Healthy Public Policy, 945 avenue Wolfe, Quebec City, Quebec, Canada.

出版信息

Soc Sci Med. 2010 May;70(10):1518-26. doi: 10.1016/j.socscimed.2010.01.036. Epub 2010 Feb 12.

DOI:10.1016/j.socscimed.2010.01.036
PMID:20207061
Abstract

There have been calls in recent years for greater public involvement in health technology assessment (HTA). Yet the concept of public involvement is poorly articulated and little attention has been paid to the context of HTA agencies. This article investigates how public involvement is conceptualized in the HTA agency environment. Using qualitative concept analysis methods, we reviewed the HTA literature and the websites of HTA agencies and conducted semi-structured interviews with informants in Canada, Denmark, and the United Kingdom. Our analysis reveals that HTA agencies' role as bridges or boundary organizations situated at the frontier of research and policymaking causes the agencies to struggle with the idea of public involvement. The HTA community is concerned with conceptualizing public involvement in such a way as to meet scientific and methodological standards without neglecting its responsibilities to healthcare policymakers. We offer a conceptual tool for analyzing the nature of public involvement across agencies, characterizing different domains, levels of involvement, and types of publics.

摘要

近年来,人们呼吁让更多公众参与卫生技术评估 (HTA)。然而,公众参与的概念尚未得到明确阐述,而且很少有人关注 HTA 机构的背景。本文研究了公众参与在 HTA 机构环境中是如何被概念化的。我们使用定性概念分析方法,审查了 HTA 文献和 HTA 机构的网站,并对来自加拿大、丹麦和英国的知情者进行了半结构化访谈。我们的分析表明,HTA 机构作为处于研究和决策制定前沿的桥梁或边界组织的角色,导致机构在公众参与的理念上存在困难。HTA 界关注的是,以一种既能满足科学和方法学标准,又不忽视其对医疗保健政策制定者责任的方式来概念化公众参与。我们提供了一个概念工具,用于分析不同机构中公众参与的性质,描述不同的领域、参与程度和公众类型。

相似文献

1
"It all depends": conceptualizing public involvement in the context of health technology assessment agencies.“一切都取决于”:在卫生技术评估机构背景下对公众参与的概念化。
Soc Sci Med. 2010 May;70(10):1518-26. doi: 10.1016/j.socscimed.2010.01.036. Epub 2010 Feb 12.
2
Moving cautiously: Public involvement and the health technology assessment community.谨慎前行:公众参与和卫生技术评估共同体。
Int J Technol Assess Health Care. 2011 Jan;27(1):43-9. doi: 10.1017/S0266462310001200. Epub 2011 Jan 25.
3
Role of patient and public participation in health technology assessment and coverage decisions.患者和公众参与在卫生技术评估和覆盖决策中的作用。
Expert Rev Pharmacoecon Outcomes Res. 2011 Feb;11(1):75-89. doi: 10.1586/erp.10.82.
4
Public engagement in health technology assessment and coverage decisions: a study of experiences in France, Germany, and the United Kingdom.公众参与卫生技术评估和覆盖决策:法国、德国和英国的经验研究。
J Health Polit Policy Law. 2013 Feb;38(1):89-122. doi: 10.1215/03616878-1898812. Epub 2012 Oct 10.
5
[Requirements for and expectations of health technology assessment in Galicia (Spain). A qualitative study from the perspective of decision-makers and clinicians].[西班牙加利西亚地区卫生技术评估的要求与期望。一项从决策者和临床医生角度开展的定性研究]
Gac Sanit. 2011 Nov-Dec;25(6):454-60. doi: 10.1016/j.gaceta.2011.05.014. Epub 2011 Aug 5.
6
Redefining health technology assessment in Canada: diversification of products and contextualization of findings.重新定义加拿大的卫生技术评估:产品多样化与研究结果情境化
Int J Technol Assess Health Care. 2004 Summer;20(3):325-36. doi: 10.1017/s026646230400114x.
7
[Citizen participation in the context of health technology assessment].[公民在卫生技术评估背景下的参与]
Rev Med Chil. 2014 Jan;142 Suppl 1:S27-32. doi: 10.4067/S0034-98872014001300005.
8
STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.国家层面利益相关者参与卫生技术评估:来自伊朗的一项研究
Int J Technol Assess Health Care. 2016 Jan;32(3):181-9. doi: 10.1017/S0266462316000167. Epub 2016 Aug 15.
9
Health technology assessment of medical devices: a survey of non-European union agencies.医疗器械的卫生技术评估:对非欧盟机构的一项调查
Int J Technol Assess Health Care. 2015 Jan;31(3):154-65. doi: 10.1017/S0266462315000185. Epub 2015 Jun 5.
10
Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.卫生技术评估(HTA)案例研究:影响澳大利亚、加拿大、英格兰和苏格兰卫生技术评估报销建议分歧的因素
Value Health. 2017 Mar;20(3):320-328. doi: 10.1016/j.jval.2016.10.014. Epub 2016 Dec 22.

引用本文的文献

1
Stakeholder perspectives on the current status and potential barriers of patient involvement in health technology assessment (HTA) across Europe.欧洲利益相关者对患者参与卫生技术评估(HTA)的现状及潜在障碍的看法。
Int J Technol Assess Health Care. 2024 Dec 19;40(1):e81. doi: 10.1017/S0266462324004707.
2
Involving Patients in Hospital-Based Health Technology Assessment of Innovative Medical Devices: Adapting to a Specific Local Context and Lessons Learned From the Assessment of an Ex Vivo Perfusion System of Human Donor Hearts.让患者参与基于医院的创新医疗设备卫生技术评估:适应特定的当地情况以及从人体供体心脏体外灌注系统评估中吸取的经验教训。
Health Expect. 2024 Dec;27(6):e70119. doi: 10.1111/hex.70119.
3
Trends in Government-Initiated Public Engagement in Canadian Health Policy From 2000 to 2021.
2000 年至 2021 年加拿大卫生政策中政府主导的公众参与趋势。
Healthc Policy. 2024 Sep;20(SP):17-35. doi: 10.12927/hcpol.2024.27416.
4
Experiences of patient organizations' involvement in medicine appraisal and reimbursement processes in Finland - a qualitative study.芬兰患者组织参与药品评估和报销流程的经验 - 一项定性研究。
Int J Technol Assess Health Care. 2024 Jul 2;40(1):e26. doi: 10.1017/S0266462324000229.
5
A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.尼日利亚决策者的 COVID-19 疫苗接种卫生技术评估:确定利益相关者和支持证据采用的途径。
Health Res Policy Syst. 2024 Jun 26;22(1):73. doi: 10.1186/s12961-024-01158-y.
6
Strategies for engaging older adults and informal caregivers in health policy development: A scoping review.让老年人和非正式照护者参与健康政策制定的策略:一项范围综述。
Health Res Policy Syst. 2024 Feb 19;22(1):26. doi: 10.1186/s12961-024-01107-9.
7
Patient and citizen participation at the organizational level in health technology assessment: an exploratory study in five jurisdictions.患者和公民在卫生技术评估中的组织层面参与:五个司法管辖区的探索性研究。
Int J Technol Assess Health Care. 2023 Aug 8;39(1):e51. doi: 10.1017/S0266462323000417.
8
Patient-based evidence: its role in decision making on end-of-life, orphan, and ultra-orphan medicines.基于患者的证据:在生命末期、孤儿和超孤儿药物决策中的作用。
Int J Technol Assess Health Care. 2023 Apr 11;39(1):e19. doi: 10.1017/S026646232300003X.
9
Strategies for engaging senior citizens and their informal caregivers in health policy development: a scoping review protocol.策略制定以让老年人及其非正式照护者参与卫生政策制定:范围综述研究方案。
BMJ Open. 2022 Oct 5;12(10):e064505. doi: 10.1136/bmjopen-2022-064505.
10
Mapping the role of patient and public involvement during the different stages of healthcare innovation: A scoping review.绘制患者和公众参与医疗创新不同阶段的作用图谱:范围综述。
Health Expect. 2022 Jun;25(3):840-855. doi: 10.1111/hex.13437. Epub 2022 Feb 17.